On Friday May 1 Gilead’s investigational antiviral drug Remdesivir received emergency use authorization for the treatment of COVID-19. Gilead’s CEO Dan O’day indicated “We intend to get that to patients in the early part of this next week,” while on CBS’ “Face of the Nation”.
He went on to state that Gilead has donated 1.5 million vials of Remdesivir, which can treat 100,000 to 200,000 people, to the government. The federal government will distribute these treatments according to need in cities throughout the country. Treatments are expected to be in the hands of doctors and nurses in the upcoming days. According to the CDC there have been over 1.12 million confirmed cases of COVID-19 and over 65,000 deaths in the U.S.